Clinical Trial

A Study of HS-20137 in Participants with Moderate-to-severe Plaque Psoriasis

Name: A Study of HS-20137 in Participants with Moderate-to-severe Plaque Psoriasis — clinical trial record (NCT06844799)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting Phase 3

View on ClinicalTrials.gov →

Summary

The primary objective of this study is to evaluate the efficacy and safety of HS-20137 in the treatment of participants with moderate to severe plaque psoriasis.

Trial Details

NCT Number	NCT06844799
Lead Sponsor	Hansoh BioMedical R&D Company
Conditions	Moderate-to-severe Plaque Psoriasis
Enrollment	720 participants
Start Date	2025-06-10
Primary Completion	2027-03-31 (estimated)
Study Completion	2027-06-30 (estimated)
Updated on ClinicalTrials.gov	2025-02-25